Magnesium and cardiovascular system

Magnesium Research

Volumn 23, Issue 2, 2010, Pages 60-72

  Shechter, Michael ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Diabetes; Endothelium; Heart disease; Hypertension; Magnesium; Myocardial infarction; Nutrition; Platelets

Indexed keywords

ANTICOAGULANT AGENT; MAGNESIUM;

ARTICLE; BLOOD; BLOOD VESSEL; CARDIOVASCULAR SYSTEM; DRUG EFFECT; HUMAN; LIPID METABOLISM; METABOLISM; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANTICOAGULANTS; BLOOD VESSELS; CARDIOVASCULAR SYSTEM; ENDOTHELIUM, VASCULAR; HUMANS; LIPID METABOLISM; MAGNESIUM;

ANIMALIA;

EID: 77954446933     PISSN: 09531424     EISSN: 19524021     Source Type: Journal    
DOI: 10.1684/mrh.2010.0202     Document Type: Article

References (118)

1. Seelig MS, Rosanoff A. The magnesium factor. New York: Avery, 2003.
2. Wacker WEC, Parisi AF. Magnesium metabolism. N Engl J Med 1968; 278: 658-63.
3. Shechter M, Kaplinsky E, Rabinowitz B. The rationale of magnesium supplementation in acute myocardial infarction. A review of the literature. Arch Intern Med 1992; 152: 2189-96.
4. Whang R, Flink E, Dyckner T, Wester PO, Aikawa JK, Ryan MP. Magnesium depletion as a cause of refractory potassium repletion. Arch Intern Med 1985; 145: 1686-9.
5. Ryzen E, Elkayam U, Rude RK. Low blood mononuclear cell magnesium content in intensive cardiac care unit patients. Am Heart J 1986; 111: 475-80.
6. Reinhart RA. Magnesium metabolism. Arch Intern Med 1988; 148: 2415-20.
7. Elin RJ. Status of the determination of magnesium in mononuclear blood cells in humans. Magnesium 1988; 7: 300-5.
8. Haigney MCP, Silver B, Tanglao E, Silverman HS, Hill JD, Shapiro E, Gerstenblith G, Schulman SP. Noninvasive measurement of tissue magnesium and correlation with cardiac levels. Circulation 1995; 92: 2190-7.
9. Cohen L. Physiologic assessment of magnesium status in humans: a combination of load retention and renal excretion. IMAJ 2000; 2: 938-9.
10. Seelig MS. The requirement of magnesium by the normal adult. Am J Clin Nutr 1964; 6: 342-90.
11. Centers for Disease Control and Prevention. Dietary intake of vitamins, minerals, and fiber of persons ages 2 months and over in the United States: Third National Health and Nutrition Examination Survey, Phase I, 1988-91. Advance data from vital and health statistics; no 258. Hyattsville, MD: National Center for Health Statistics, 1994: 1-28.
12. Lowenstein FW, Stanton MF. Serum magnesium levels in the United States, 1971-1974. J Am Coll Nutr 1986; 5: 399-414.
13. Seelig MS. Cardiovascular consequences of magnesium deficiency and loss: Pathogenesis, prevalence and manifestations-magnesium and chloride loss in refractory potassium repletion. Am J Cardiol 1989; 63: 4G-21G.
14. Lichton IJ. Dietary intake levels of requirements of Mg and Ca for different segments of the U.S. population. Magnesium 1989; 8: 117-23.
15. Peterson DR, Thompson DJ, Nam JM. Water hardness, arteriosclerotic heart disease and sudden death. Am J Epidemiol 1970; 92: 90-3.
16. Shaper AG. Soft water, heart attacks, and stroke. J Am Med Assoc 1974; 230: 130-1.
17. Anderson TW, Neri LC, Schreiber GB, Talbot FD, Zdrojewski A. Ischemic heart disease, water hardness and myocardial magnesium. CMA J 1975; 113: 199-203.
18. Liao F, Folsom AR, Brancati FL. Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 1998; 136: 480-90.
19. Ford ES. Serum magnesium and ischemic heart disease: findings from national sample of US adults. Int J Epidemiol 1999; 28: 645-51.
20. Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, Yano K, Curb JD Abbott RD, Ando F, Masaki KH, Tung KH, Rodriguez BL, Petrovitch H, Yano K, Curb JD. Dietary Magnesium Intake and the Future Risk of Coronary Heart Disease (The Honolulu Heart Program). Am J Cardiol 2003; 92: 665-9.
21. Amighi J, Sabeti S, Schlager O, Mlekusch W, Exner M, Lalouschek W, Ahmadi R, Minar E, Schillinger M. Low Serum Magnesium Predicts Neurological Events in Patients With Advanced Atherosclerosis. Stroke 2004; 35: 22-7.
22. He K, Liu K, Daviglus ML, Morris SJ, Loria CM, Van Horn L, Jacobs DR Jr, Savage PJ. Magnesium Intake and Incidence of Metabolic Syndrome Among Young Adults. Circulation 2006; 113: 1675-82.
23. Pachikian BD, Neyrinck AM, Deldicque L, De Backer FC, Catry E, Dewulf EM, Sohet FM, Bindels LB, Everard A, Francaux M, Guiot Y, Cani PD, Delzenne NM. Changes in intestinal bifidobacteria levels are associated with the inflammatory response in magnesium-deficient mice. J Nutr 2010; 140: 509-14.
24. Lin CY, Tsai PS, Hung YC, HuangCJ. L-typecalcium channels are involved in mediating the anti-inflammatory effects of magnesium sulphate. Br J Anaesth 2010; 104: 44-51.
25. King DE. Inflammation and elevation of C-reactive protein: does magnesium play a key role? Magnes Res 2009; 22: 57-9.
26. Song Y, Li TY, van Dam RM, Manson JE, Hu FB. Magnesium intake and plasma concentrations of markers of systemic inflammation and endothelial dysfunction in women. Am J Clin Nutr 2007; 85: 1068-74.
27. Chacko SA, Song Y, Nathan L, Tinker L, de Boer IH, Tylavsky F, Wallace R, Liu S. Relations of dietary magnesium intake to biomarkers of inflammation and endothelial dysfunction in an ethnically diverse cohort of postmenopausal women. Diabetes Care 2010; 33: 304-10.
28. Shechter M, Kaplinsky E, Rabinowitz B. Review of clinical evidence - is there a role for supplemental magnesium in acute myocardial infarction in high-risk populations (patients ineligible for thrombolysis and the elderly)? Coron Artery Dis 1996; 7: 352-8.
29. Shechter M. Does Magnesium have a Role in the Treatment of Patients with Coronary Artery Disease? Am J Cardiovasc Drugs 2003; 3: 231-9.
30. Shechter M, Shechter A. Magnesium and myocardial infarction. Clin Calcium 2005; 11: 111-5.
31. Iseri LT, French JH. Magnesium: nature's physiologic calcium blocker. Am Heart J 1984; 108: 188-93.
32. Holroyde MJ, Robertson SP, Johnson JD, Solaro RJ, Potter JD. The calcium and magnesium bindig sites on cardiac troponin and their role in the regulation of myofibrillar adenosine triphosphatase. J Biol Chem 1980; 255: 11688-91.
33. Sordahl LA. Effects of magnesium on initial rates of calcium uptake and release of heart mitochondria. Arch Biochem Biophys 1975; 167: 104-7.
34. Mroczek WJ, Lee WR, Davidov ME. Effect of magnesium sulfate on cardiovascular hemodynamics. Angiology 1977; 28: 720-4.
35. Cotton DB, Gonik B, Dorman KF. Cardiovascular alterations in severe pregnancy-induced hypertension: acute effects of intravenous magnesium sulfate. Am J Obstet Gynecol 1984; 148: 162-5.
36. Rasmussen HS, Larsen OG, Meier K, Larsen J. Hemo dynamic effects of intravenous administered magnesium in patients with ischemic heart disease. Int J Cardiol 1988; 11: 824-8.
37. Altura BM, Altura BT. New perspectives on the role of magnesium in the pathophysiology of the cardiovascular system. Magnesium 1985; 4: 245-71.
38. Altura BM. Magnesium neurohypophysal hormone interactions in contraction of vascular smooth muscle. Am J Physiol 1975; 228: 1615-20.
39. Altura BM, Altura BT, Corella A. Magnesium deficiency-induced spasms of umbilical vessels: relation to preeclampsia, hypertension, growth retardation. Science 1983; 221: 376-8.
40. Altura BM, Altura BT. Vascular smooth muscle and prostaglandins. Fed Proc 1976; 35: 2360-6.
41. Askar AD, Mustafa SJ. Role of magnesium in the relaxation of coronary arteries by adenosine. Magnesium 1983; 2: 17-25.
42. Whelton PK, Klay MJ. Magnesium and blood pressure: review of the epidemiologic and clinical trial experience. Am J Cardiol 1989; 63: 26G-30G.
43. Mizushima S, Cappuccio FP, Nichols R, Elliott P. Dietary magnesium intake and blood pressure: a qualitative overview of the observational studies. J Hum Hypertens 1998; 12: 447-53.
44. Kugiyama K, Yasue H, Okumara K, Goto K, Minoda K, Miyagi H, Matsuyama K, Kojima A, Koga Y, Takahashi M. Suppression of exercise-induced angina by magnesium sulfate in patients with variant angina. J Am Coll Cardiol 1988; 12: 1177-83.
45. Jee HS, Miller ER 3rd, Guallar E, Singh VK, Appel LJ, Klag MJ. The effect of magnesium supplementation on blood pressure. A meta analysis of clinical randomized trials. Am J Hypertens 2002; 15: 691-6.
46. Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 105-201.
47. Shechter M, Paul-Labrador M, Rude RK, Bairey Merz CN. Intracellular magnesium predicts functional capacity in patients with coronary artery disease. Cardiology 1998; 90: 168-72.
48. Shechter M, Bairey Merz CN, Stuehlinger HG, Slany J, Pachinger O, Rabinowitz B. Oral magnesium supplementation improves exercise duration and quality of life in patients with coronary artery disease. Am J Cardiol 2003; 91: 517-21.
49. Pokan R, Hofmann P, von Duvillard SP, Smekal G, Wonisch M, Lettner K, Schmid P, Shechter M, Silver B, Bachl N. Oral magnesium therapy, exercise heart rate, exercise tolerance, and myocardial function in coronary artery disease patients. Br J Sports Med 2006; 40: 773-8.
50. Greville GD, Lehmann H. Cation antagonism in blood coagulation. J Physiol 1943; 103: 175-84.
51. Schnitzler B. Thromboseprophylaxe mit Magnesium. Munch med Wschr 1957; 99: 81-4.
52. Anstall HB, Huntsman RG, Lehmann H, Weitzman D, Lehmann H. The effect of magnesium on blood coagulation in human subjects. Lancet 1959; 1: 814-5.
53. Adams JH, Mitchel JRA. The effect of agents which modify platelet behavior and of magnesium ions on thrombus formation in vivo. Thromb Haemost 1979; 42: 603-10.
54. Frandsen NJ, Winther K, Pedersen F, Christiansen I, McNair P. Magnesium and platelet function: in vivo influence on aggregation and alpha-granule release in healthy volunteers. Magnesium Bull 1995; 17: 37-40.
55. Hwang DL, Yen CF, Nadler JL. Effect of extracellular magnesium on platelet activation and intracellular calcium mobilization. Am J Hypertens 1992; 5: 700-6.
56. Born GVR, Cross GP. Effect of inorganic ions and plasma proteins on the aggregation of blood platelets by adenosine diphosphate. J Physiol 1964; 170: 397-414.
57. Gawaz M, Ott I, Reininger AJ, Neumann FJ. Effects of magnesium on platelet aggregation and adhesion. Magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Thromb Haemost 1994; 72: 912-8
58. Nadler JL, Goodson S, Rude RK. Evidence that prostacyclin mediates the vascular action of magnesium in humans. Hypertension 1987; 9: 379-83.
59. Gawaz M. Effects of intravenous magnesium on platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Thromb Res 1996; 83: 341-9.
60. Badimon L, Badimon JJ, Galvez A, Chesebro JH, Fuster V. Influence of arterial damage and wall shear rate on platelet formation: ex vivo study in a swine model. Arteriosclerosis 1986; 6: 312-20.
61. Shechter M, Bairey Merz CN, Rude RK, Paul Labrador MJ, Meisel SR, Shah PK, Kaul S. Low intracellular magnesium levels promote platelet-dependent thrombus formation in patients with coronary artery disease. Am Heart J 2000; 140: 212-8.
62. Shechter M, Bairey Merz CN, Paul-Labrador M, Meisel SR, Rude RK, Molloy MD, Dwyer JH, Shah PK, Kaul S. Oral magnesium supplementation inhibits platelet-dependent thrombosis in patients with coronary artery disease. Am J Cardiol 1999; 84:152-6.
63. Rukshin V, Azarbal B, Shah PK, Tsang VT, Shechter M, Cercek B, Kaul S. Intravenous magnesium in experimental stent thrombosis in swine. Arterioscler Thromb Vasc Biol 2001; 21: 1544-9.
64. Rukshin V, Shah PK, Cercek B, Finkelstein A, Tsang V, Kaul S. Comparative antithrombotic effects of magnesium sulfate and platelet glycoprotein IIb/IIIa inhibitors tirofiban and eptifibatide in a canine model of stent thrombosis. Circulation 2002; 105: 1970-5.
65. Rukshin V, Santos R, Gheorghiu M, Shah PK, Kar S, Padmanabhan S, Azarbal B, Tsang VT, Makkar R, Samuels B, Lepor N, Geft I, Tabak S, Khorsandhi M, Buchbinder N, Eigler N, Cercek B, Hodgson K, Kaul S. A prospective, nonrandomized, open-labeled pilot study investigating the use of magnesium in patients undergoing nonacute percutaneous coronary intervention with stent implantation. J Cardiovasc Pharmacol Ther 2003; 8: 193-200.
66. Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction. Endothelial dysfunction. A marker of atherosclerotic risk. Arteriosc Thromb Vasc Biol 2003; 23: 168-75.
67. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, Deanfield J, Drexler H, Gerhard-Herman M, Herrington D, Vallance P, Vita J, Vogel R; International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery. J Am Coll Cardiol 2002; 39: 257-65.
68. Vogel RA. Coronary risk factors, endothelial function, and atherosclerosis: A review. Clin Cradiol 1997; 20: 426-32.
69. McLenachan JM, Williams JK, Fish RD, Ganz P, Selwyn AP. Loss of flow-mediated endothelium-dependent dilation occurs early in the development of atherosclerosis. Circulation 1991; 84: 1272-7.
70. Rizzoni D. Endothelial function in hypertension: fact or fantasy? J Hypertens 2002; 20: 1479-81.
71. Drexler H, Hayoz D, Münzel T, Hornig B, Just H, Brunner HR, Zelis R. Endothelial function in chronic congestive heart failure. Am J Cardiol 1992; 69: 1596-601.
72. Widlansky ME, Gokce N, Keaney JF Jr, Vita JA. The clinical implication of endothelial dysfunction. J Am Coll Cardiol 2003; 42: 1149-60.
73. Lerman A, Zeiher AM. Endothelial function cardiac events. Circulation 2005; 111: 363-8.
74. Shechter M, Sherer Y. Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk? Isr Med Assoc J 2003; 5: 736-8.
75. Shechter M, Sharir M, Paul Labrador M, Labrador MJ, Forrester J, Silver B, Bairey Merz CN. Oral magnesium therapy improves endothelial function in patients with coronary artery disease. Circulation 2000; 102: 2353-8.
76. Pearson PJ, Evora PR, Seccombe JF, Schaff HV. Hypo-magnesemia inhibits nitric oxide release from coronary endothelium: protective role of magnesium infusion after cardiac operations. Ann Thor Surg 1998; 65: 967-72.
77. Paravicini TM, Yogi A, Mazur A, Touyz RM. Dysregulation of vascular TRPM7 and annexin-1 is associated with endothelial dysfunction in inherited hypomagnesemia. Hypertension 2009; 53: 423-9.
78. Vormann J, Fiscer G, Classen HG, Thöni H. Influence of decreased and increased magnesium supply on cardiotoxic effects of epinephrine in rats. Arzneimittel-forschung 1983; 33: 205-10.
79. Banai S, Haggroth L, Epstein SE. Influence of extracellular magnesium on capillary endothelial cell proliferation and migration. Circ Res 1990; 67: 645-50.
80. Weisman HF, Bush DE, Mannisi JA, Casscells W. Cellular mechanisms of myocardial infarct expansion. Circulation 1988; 78: 186-201.
81. Dickens BF, Weglicki WB, Li YS, Mak IT. Magnesium deficiency in vitro enhances free radical-induced intracellular oxidation and cytotoxicity in endothelial cells. FEBS 1992; 311: 187-91.
82. Rasmussen HS, Aurup P, Goldstein K, McNair P, Mortensen PB, Larsen OG, Lawaetz H. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. Arch Intern Med 1989; 149: 1050-3.
83. Davis WH, Leary WP, Reyes AH. Monotherapy with magnesium increases abnormally low high density lipoprotein cholesterol: A clinical assay. Curr Ther Res 1984; 36: 341-4.
84. Niemela JE, Csako G, Bui MN, Elin RJ. Gender-specific correlation of platelet ionized magnesium and serum low-density cholesterol concentrations in apparently healthy subjects. J Lab Clin Med 1997; 129: 89-96.
85. Ouchi Y, Tabata RE, Stergiopoulos K, Sato F, Hattori A, Orimo H. Effect of dietary magnesium on development of atherosclerosis in cholesterol fed rabbits. Arteriosclerosis 1990; 10: 732-7.
86. Rayssiguier Y, Guex E, Weiser D. Effect of magnesium deficiency on lipid metabolism in rats fed a high carbohydrate diet. J Nutr 1981; 111: 1876-83.
87. Luthringer C, Rayssiguier Y, Gueux E, Berthelot A. Effect of moderate magnesium deficiency on serum lipids, blood pressure and cardiovascular reactive in normotensive rats. Br J Nut 1988; 59: 243-50.
88. Beller GA, Hood WB Jr, Abelmann WH, Abelmann WH, Wacker WE. Correlation of serum magnesium levels and cardiac digitalis intoxication. Am J Cardiol 1974; 33: 225-9.
89. Arsenian MA. Magnesium and cardiovascular disease. Prog Cardiovasc Dis 1993; 35: 271-310.
90. Zwillinger L. Über die Magnesiumwirkung auf das Herz. Klin Wochenschr 1935; 14: 1329-433.
91. Chadda KD, Lichstein E, Gapta P. Hypomagnesemia and refractory cardiac arrhythmia in a nondigitalized patient. Am J Cardiol 1973; 31: 98-100.
92. Tzivoni D, Keren A. Suppression of ventricular arrhythmias by magnesium. Am J Cardiol 1990; 65: 1397-9.
93. Tzivoni D, Keren A, Cohen AM, Loebel H, Zahavi I, Chenzbraun A, Stern S. Magnesium therapy for torsade de pointes. Am J Cardiol 1984; 53: 528-30.
94. Lloyd T, Iseri MD, Fairshter R, Iseri LT, Fairshter RD, Hardemann JL, Brodsky MA. Magnesium and potassium therapy in multifocal atrial tachycardia. Am Heart J 1985; 110: 789-94.
95. Horner SM. Efficacy of intravenous magnesium in acute myocardial infarction in reducing arrhythmias and mortality. Circulation 1992; 86: 774-9.
96. Morton BC, Nair RC, Smith FM, McKibbon TG, Poznanski WJ. Magnesium therapy in acute myocardial infarction. Magnesium 1984; 3: 346-52.
97. Rasmussen HS, McNair P, Norregard P, Backer V, Lindeneg O, Balslev S. Magnesium infusion in acute myocardial infarction. Lancet 1986; 1: 234-6.
98. Rasmussen HS, Grønbaek M, Cintin C, Balsløv S, Nørregård P, McNair P. One-year rate in 270 patients with suspected acute myocardial infarction, initially treated with intravenous magnesium or placebo. Clin Cardiol 1988; 11: 377-81.
99. Smith LF, Heagerty AM, Bing RF, Barnett DB. Intravenous infusion of magnesium sulphate after acute myocardial infarction: effects on arrhythmias and mortality. Int J Cardiol 1986; 12: 175-80.
100. Abraham AS, Rosenman D, Meshulam Z, Balkin J, Zion MM, Farbstien H, Eylath U. Magnesium in the prevention of lethal arrhythmias in acute myocardial infarction. Arch Intern Med 1987; 147: 753-5.
101. Ceremuzynski L, Jurgiel R, Kulakowski P, Gebalska J. Threatening arrhythmias in acute myocardial infarction are prevented by intravenous magnesium sulfate. Am Heart J 1989; 118: 1333-4.
102. Shechter M, Hod H, Marks N, Behar S, Kaplinsky E, Rabinowitz B. Beneficial effect of magnesium sulfate in acute myocardial infarction. Am J Cardiol 1990; 66: 271-4.
103. Shechter M, Hod H. Magnesium therapy in aged patients with acute myocardial infarction. Magnesium Bull 1991; 13: 7-9.
104. Feldstedt M, Boesgaard S, Bouchelouche P, Svenningsen A, Brooks L, Lech Y, Aldershvile J, Skagen K, Godtfredsen J. Magnesium substitution in acute ischaemic heart syndromes. Eur Heart J 1991; 12: 1215-8.
105. Teo KK, Yusuf S, Collins R, Held PH, Peto R. Effects of intravenous magnesium in suspected acute myocardial infarction: overview of randomized trials. Br Med J 1991; 303: 1499-503.
106. Woods KL, Fletcher S, Roffe C, Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1992; 339: 1553-8.
107. Woods KL, Fletcher S. Long term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the Second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet 1994; 343: 816-9.
108. Shechter M, Hod H, Chouraqui P, Kaplinsky E, Rabinowitz B. Magnesium therapy in acute myocardial infarction when patients are not candidates for thrombolytic therapy. Am J Cardiol 1995; 75: 321-3.
109. ISIS-4. A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58050 patients with suspected acute myocardial infarction. Lancet 1995; 345: 669-85.
110. Shechter M, Hod H, Rabinowitz B, Boyko V, Chouraqui P. Long-term outcome in thrombolysis-ineligible acute myocardial infarction patients treated with intravenous magnesium. Cardiology 2003; 99: 203-10.
111. Magnesium in Coronaries (MAGIC) trial investigators. Early administration of intravenous magnesium to high-risk patients with acute myocardial infarction in the coronaries (MAGIC) trial: a randomized controlled trial. Lancet 2002; 360: 1189-96.
112. Li J, Zhang Q, Zhang M, Egger M. Intravenous magnesium for acute myocardial infarction. Cochrane Data-base of Systematic Reviews 2007, Issue 2. Art. No.: CD002755. DOI: 10.1002/14651858.CD002755.pub2.
113. Seelig MS. Possible roles of magnesium in disorders of the aged. In: Regelson W, Sinex FM, eds. Intervention in the Aging Process. Part A: Quantitation, Epidemiology, Clinical Research. New York: AR Liss, Inc, 1983: 279-305.
114. Johansson G. Magnesium metabolism: Studies in health, primary hyperparathyroidism and renal stone disease. Scand J Urol Nephrol 1979; 51: 1-47.
115. Cohen N, Almoznino-Sarfian D, Zaidenstein R, Alon I, Gorelik O, Shteinshnaider M, Chachashvily S, Averbukh Z, Golik A, Chen-Levy Z, Modai D. Serum magnesium aberrations in furosemide (frusemide) treated patients with chronic congestive heart failure: pathophysiological correlates and prognostic evaluation. Heart 2003; 89: 411-6.
116. Fakunding JL, Chow R, Catt KJ. The role of calcium in the stimulation of aldosterone production by adrenocorticotropin, angiotensin II, and potassium in isolated glomerulosa cells. Endocrinology 1979; 105: 327-33.
117. Adamopoulos C, Pitt B, Sui X, Love TE, Zannad F, Ahmed A. Low serum magnesium and cardiovascular mortality in chronic heart failure: A propensity-matched study. Intern J Cardio 2009; 136: 270-7.
118. Stepura OB, Martynow AI. Magnesium orotate in severe congestive heart failure (MACH). Intern J Cardiol 2009; 131: 293-5.